Literature DB >> 35261453

Thrombotic microangiopathy with multiorgan involvement following COVID-19.

Bhavika Gandhi1, Deborah Jebakumar2, Matthew Nickell3, Mohanram Narayanan1.   

Abstract

Acute kidney injury is common among hospitalized COVID-19 patients, with the incidence ranging from 0.5% to 80%, due to diverse pathologies including acute tubular injury, collapsing glomerulopathy, and thrombotic microangiopathy (TMA). While macrovascular thrombosis is common in these individuals, the frequent finding of extensive microvascular thromboses in several series and case reports raises the possibility of thrombotic microangiopathy (TMA) being a contributing factor in the thrombotic and multiorgan complications of the disease. TMA has been described as either the primary finding or in concert with other pathologic findings in COVID-19 patients and carries a poor prognosis, with all patients requiring dialysis. We present a case of TMA with retinal injury and bowel perforation in addition to pulmonary and renal manifestations.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  COVID-19; dialysis; eculizumab; thrombotic microangiopathy

Year:  2021        PMID: 35261453      PMCID: PMC8865316          DOI: 10.1080/08998280.2021.1997054

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  11 in total

1.  Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.

Authors:  F Diurno; F G Numis; G Porta; F Cirillo; S Maddaluno; A Ragozzino; P De Negri; C Di Gennaro; A Pagano; E Allegorico; L Bressy; G Bosso; A Ferrara; C Serra; A Montisci; M D'Amico; S Schiano Lo Morello; G Di Costanzo; A G Tucci; P Marchetti; U Di Vincenzo; I Sorrentino; A Casciotta; M Fusco; C Buonerba; M Berretta; M Ceccarelli; G Nunnari; Y Diessa; S Cicala; G Facchini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-04       Impact factor: 3.507

Review 2.  Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily.

Authors:  Eleni Gavriilaki; Robert A Brodsky
Journal:  Br J Haematol       Date:  2020-05-23       Impact factor: 6.998

Review 3.  Viral-associated thrombotic microangiopathies.

Authors:  Rodrigo Lopes da Silva
Journal:  Hematol Oncol Stem Cell Ther       Date:  2011

4.  Malignant hypertension as a rare cause of thrombotic microangiopathy.

Authors:  Guramrinder Thind; Karthik Kailasam
Journal:  BMJ Case Rep       Date:  2017-06-08

5.  Thrombotic microangiopathy in a patient with COVID-19.

Authors:  Kenar D Jhaveri; Lea R Meir; Bessy Suyin Flores Chang; Rushang Parikh; Rimda Wanchoo; Maria Louise Barilla-LaBarca; Vanesa Bijol; Negin Hajizadeh
Journal:  Kidney Int       Date:  2020-06-07       Impact factor: 10.612

6.  Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation.

Authors:  Pedram Keshavarz; Faranak Rafiee; Hadiseh Kavandi; Sogand Goudarzi; Firouzeh Heidari; Ali Gholamrezanezhad
Journal:  Clin Imaging       Date:  2020-12-08       Impact factor: 1.605

Review 7.  Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review.

Authors:  Sagnik Sen; Naresh Babu Kannan; Jayant Kumar; Renu P Rajan; Karthik Kumar; Girish Baliga; Harshavardhan Reddy; Anubhav Upadhyay; Kim Ramasamy
Journal:  Int Ophthalmol       Date:  2021-08-11       Impact factor: 2.031

8.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Authors:  Cynthia Magro; J Justin Mulvey; David Berlin; Gerard Nuovo; Steven Salvatore; Joanna Harp; Amelia Baxter-Stoltzfus; Jeffrey Laurence
Journal:  Transl Res       Date:  2020-04-15       Impact factor: 7.012

9.  Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.

Authors:  Brian Hanley; Kikkeri N Naresh; Candice Roufosse; Andrew G Nicholson; Justin Weir; Graham S Cooke; Mark Thursz; Pinelopi Manousou; Richard Corbett; Robert Goldin; Safa Al-Sarraj; Alireza Abdolrasouli; Olivia C Swann; Laury Baillon; Rebecca Penn; Wendy S Barclay; Patrizia Viola; Michael Osborn
Journal:  Lancet Microbe       Date:  2020-08-20

10.  Successful treatment of a COVID-19 patient with thrombotic microangiopathy.

Authors:  Seda Safak; Elif Aksoy; Ahmet Burak Dirim; Erol Demir; Nurana Garayeva; Ozgur Akin Oto; Ayse Serra Artan; Halil Yazici; Sevgi Besisik; Aydin Turkmen
Journal:  Clin Kidney J       Date:  2021-01-29
View more
  1 in total

Review 1.  Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review.

Authors:  Marija Malgaj Vrečko; Andreja Aleš Rigler; Željka Večerić-Haler
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.